Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
5.60
-0.31 (-5.25%)
At close: Nov 20, 2024, 4:00 PM
5.72
+0.12 (2.14%)
After-hours: Nov 20, 2024, 6:44 PM EST
Terns Pharmaceuticals Employees
Terns Pharmaceuticals had 66 employees as of December 31, 2023. The number of employees increased by 20 or 43.48% compared to the previous year.
Employees
66
Change (1Y)
20
Growth (1Y)
43.48%
Revenue / Employee
n/a
Profits / Employee
-$1,334,439
Market Cap
475.66M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 66 | 20 | 43.48% |
| Dec 31, 2022 | 46 | 5 | 12.20% |
| Dec 31, 2021 | 41 | 11 | 36.67% |
| Dec 31, 2020 | 30 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Community Health Systems | 61,000 |
| GRAIL | 1,360 |
| Pharming Group | 382 |
| SI-BONE | 344 |
| Monte Rosa Therapeutics | 133 |
| Y-mAbs Therapeutics | 100 |
| PureTech Health | 90 |
| GH Research | 49 |
TERN News
- 2 days ago - Top 3 Health Care Stocks You'll Regret Missing In Q4 - Benzinga
- 2 days ago - Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors - GlobeNewsWire
- 5 days ago - RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking. - Market Watch
- 6 weeks ago - Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 2 months ago - Terns Pharmaceuticals: Obesity Advancement Continues With Other Q1 2025 Program Catalyst - Seeking Alpha
- 2 months ago - Undercovered Stock Picks From September 6-12: Lithium, Uranium, Gold, & Plastic - Seeking Alpha
- 2 months ago - Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 2 months ago - Terns Announces Pricing of Upsized $150.15 Million Public Offering - GlobeNewsWire